Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.
source https://www.nytimes.com/2021/08/25/us/politics/biden-coronavirus-vaccine.html
एक टिप्पणी भेजें
एक टिप्पणी भेजें